Brief: ALX Oncology Q2 Basic EPS USD -0.76
08/08/2024 21:05
Aug 08 (Reuters) - ALX Oncology Q2 operating expenses USD 41.525 million. * Q2 income from operations USD -41.525 million vs. IBES estimate USD -39.3 million * Q2 net income USD -39.399 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing